ISB News

ISB Post Doc Gets Patent for Protein that Blocks HIV

MartinShelton
Martin Shelton

Martin Shelton, a post doc in the Lee Hood lab, just received his first patent. He shared the following explanation with his 10-year-old nephew who’s a burgeoning scientist/inventor/engineer.

“We made a small molecule called a peptide (which is a sciency word for a piece of a protein). This peptide blocks a function that is key to the spread of the Human Immunodeficiency Virus (HIV, the virus that causes AIDS) within a person by trapping the virus within the infected cell and preventing it from infecting surrounding cells. It knocks out a similar function in cancer that could hinder tumor growth and the spread of cancer from one part of the body to another. We think it could one day be used to help treat HIV/AIDS or cancer, but it still has a long way to go and would have to pass many, many more tests before it could be used as a medicine. But in the meantime, it’s a useful tool for studying certain aspects of these diseases.”

Congratulations, Martin!

20130502-184513.jpg

Recent Articles

  • ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever 

    ISB Associate Professor Dr. Wei Wei and his colleagues have developed a promising new companion diagnostic tool called MetaboCore to help physicians quickly select the most effective systemic therapy for each cancer patient. 

  • Spotlight on ISB Education graphic

    2024-25 School Year ISB Education Highlights

    In the November installment of the 2024-25 academic year roundup, we highlight some of the top projects the ISB Education team is working on. This month, ISB hosted Ignite STEM, an annual fundraiser that raised more than $50,000 for the ISB Education team’s important work, and more.

  • Drs. Jennifer Hadlock and Alexandra Ralevski

    ISB Study Highlights AI’s Potential and Pitfalls in Analyzing Health Data

    New peer-reviewed research out of ISB highlights the strengths of large language models in uncovering social determinants of health while underscoring the need for human oversight and improved de-identification methods.